Two more Chinese drugmakers have said that a blood-pressure medication they exported to Taiwan contained a potentially cancer-causing impurity, a month after the same problem at another Chinese manufacturer prompted a global recall.
Tianyu Pharm and Rundu Pharma said batches of valsartan, an active ingredient widely used in medications for high blood pressure and congestive heart failure, contained N-nitrosodimethylamine (NDMA), which is believed to potentially cause cancer through long-term use.
Tianyu Pharm made its announcement yesterday in a statement to the Shenzhen Stock Exchange, where both companies are listed, while Rundu said the same in an exchange statement on Friday.
Tianyu Pharm said the problem was caught before its valsartan was distributed to end users in Taiwan, while Rundu Pharma said its products made it onto Taiwan’s market, but would be recalled.
The Food and Drug Administration on Thursday ordered a recall of 24.21 million tablets of heart medicine valsartan supplied by Zhuhai Rundu Pharmaceutical Co were found to be tainted.
The recall was instigated after it was discovered that Zhuhai’s valsartan contained NDMA.
The four types of medicines affected are the Valsart FC Tab 160mg, Valsart FC Tab 80 mg, Asartan FC Tab 5/80mg and the Valsart-H FC Tablets 80/12.5mg, which is produced by Standard Chem & Pharm Co in Taiwan.
More than 10 million tablets from six types of valsartan medicine supplied by Zhejiang Huahai Pharmaceuticals were recalled last month after they were found to be tainted by NDMA.
A drunk woman was sexually assaulted inside a crowded concourse of Taipei Railway Station on Thursday last week before a foreign tourist notified police, leading to calls for better education on bystander intervention and review of security infrastructure. The man, surnamed Chiu (邱), was taken into custody on charges of sexual assault, taking advantage of the woman’s condition and public indecency. Police discovered that Chiu was a fugitive with prior convictions for vehicle theft. He has been taken into custody and is to complete his unserved six-month sentence, police said. On Thursday last week, Chiu was seen wearing a white
EVA Airways, one of the leading international carriers in Taiwan, yesterday said that it was investigating reports that a cabin crew manager had ignored the condition of a sick flight attendant, who died on Saturday. The airline made the statement in response to a post circulating on social media that said that the flight attendant on an outbound flight was feeling sick and notified the cabin crew manager. Although the flight attendant grew increasingly ill on the return flight, the manager did not contact Medlink — a system that connects the aircraft to doctors on the ground for treatment advice during medical
The Taoyuan Flight Attendants’ Union yesterday vowed to protest at the EVA Air Marathon on Sunday next week should EVA Airway Corp’s management continue to ignore the union’s petition to change rules on employees’ leave of absence system, after a flight attendant reportedly died after working on a long-haul flight while ill. The case has generated public discussion over whether taking personal or sick leave should affect a worker’s performance review. Several union members yesterday protested at the Legislative Yuan, holding white flowers and placards, while shouting: “Life is priceless; requesting leave is not a crime.” “The union is scheduled to meet with
‘UNITED FRONT’ RHETORIC: China’s TAO also plans to hold weekly, instead of biweekly, news conferences because it wants to control the cross-strait discourse, an expert said China’s plan to expand its single-entry visa-on-arrival service to Taiwanese would be of limited interest to Taiwanese and is a feeble attempt by Chinese administrators to demonstrate that they are doing something, the Mainland Affairs Council said yesterday. China’s Taiwan Affairs Office (TAO) spokesman Chen Binhua (陳斌華) said the program aims to facilitate travel to China for Taiwanese compatriots, regardless of whether they are arriving via direct flights or are entering mainland China through Hong Kong, Macau or other countries, and they would be able to apply for a single-entry visa-on-arrival at all eligible entry points in China. The policy aims